MSD
A Biologics Process Research & Development organization within the Research & Development Division develops drug substance manufacturing processes for biologics pipeline, working closely with colleagues in Discovery, Pre-clinical, and Early Development to rapidly develop manufacturing processes and efficiently manufacture material for clinical trials.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
42% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Associate Principal Scientist, Upstream Process Development
Merck & Co., Inc.
Associate Principal Scientist, Upstream Development
Merck & Co., Inc.
Associate Principal Scientist, Upstream Development
Merck & Co., Inc.
Associate Principal Scientist, Biologics Process R&D
Merck & Co., Inc.
Associate Principal Scientist, Sterile Product Development
Merck & Co., Inc.
Associate Principal Scientist, Sterile Product Development
Merck & Co., Inc.